Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Migraine vertigo study pulled before start: drug vs lifestyle showdown never happened

NCT ID NCT06417684

Symptom relief Sponsor: Vanderbilt University Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study was designed to see whether the drug amitriptyline or lifestyle changes work better for people with vestibular migraine, a condition that causes dizziness and headache. The plan was to randomly assign adults with definite vestibular migraine to one of the two treatments and track their symptoms for up to a year. However, the study was withdrawn before enrolling any participants, so no results are available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Early phase 1

The earliest testing in people: a first look at safety, in a very small group.

Started

Jun 2024

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * English-speaking adults * Diagnosed with Definite Vestibular Migraine * Currently prescribed rescue medication for migraine is acceptable Exclusion Criteria: * Non-English speaking * Diagnosed and undergoing treatment for active Definite Meniere's disease * Already using amitriptyline * Contraindicated for intervention with amitriptyline including: * Patients with Hepatic Impairment * Patients with Renal Impairment * Pregnancy * Breastfeeding * Elderly Patients * Allergy to amitriptyline * Heart attack * Used an MAO inhibitor in the past 14 days * Used an "SSRI" antidepressant in the past 5 weeks * Bipolar disorder (manic-depression) or schizophrenia * Mental illness or psychosis * Stroke * Seizures * Diabetes * Glaucoma * Problems with urination

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Vestibular migraine are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

migraine with brainstem aura

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Vestibular migraine

Contacts and locations

Locations

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.